Overview

A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy

Status:
Completed
Trial end date:
2020-03-31
Target enrollment:
Participant gender:
Summary
This is a Phase 2, randomized, double-blind, 2-part comparator- and placebo-controlled study to evaluate the safety, PK, and efficacy of TLC590 via a single infiltrative local administration in adult subjects following bunionectomy.
Phase:
Phase 2
Details
Lead Sponsor:
Taiwan Liposome Company
Treatments:
Bupivacaine
Ropivacaine